O&G Vivas · Neonatal care — metabolic and transitional care
Neonatal hypoglycaemia — structured oral station (12 minutes)
FRANZCOG oral-format station on an at-risk hypoglycaemic newborn: candidate applies the operational threshold, prescribes buccal dextrose gel 200 mg/kg with the evidence, escalates appropriately, and supports breastfeeding. Scored against the eight published RANZCOG oral domains.
On this page
Study tools
Target exams
Station format
4 minutes reading, 12 minutes examination, 20 marks, global scoring. The eight published RANZCOG oral domains apply to every station. You are marked on how you apply the operational threshold, defend your gel dose with evidence, and protect the breastfeeding relationship while you treat.[1]
Reveal the examiner script and model responsesShowHide
Opening prompt — "What is your threshold to treat, and what do you do first?"
Model response: [1]
- "There is no single glucose number that defines brain injury — I use an operational threshold. In the first 48 hours, under 2.6 mmol/L is my treatment threshold. This baby is 1.9 and symptomatic, so the hypoglycaemia is critical."[1]
- "I give 40% glucose gel 0.5 mL/kg — that is 200 mg/kg — massaged into the buccal mucosa, followed by a feed, and recheck at 30 minutes. Because he is symptomatic I also establish intravenous access in parallel."[1][2]
Examiner is listening for: the operational-threshold framing, the correct gel dose, and the recognition that symptomatic means critical. [1]
Probe 1 — "What evidence supports the gel?"
- "The Sugar Babies trial: 40% dextrose gel 200 mg/kg reduced treatment failure from 24% to 14% — relative risk 0.57 — with no serious adverse events, in late-preterm and term babies in the first 48 hours."[2]
- "The Cochrane review concluded oral dextrose gel is probably an effective and safe first-line treatment; it also reduced mother-infant separation and increased exclusive breastfeeding after discharge."[3]
Probe 2 — "The glucose is still low after gel and a feed. What now?"
- "That is critical hypoglycaemia. I start a 10% glucose infusion at 60 mL/kg/day — 80 mL/kg/day because he is symptomatic — with a 1 mL/kg 10% glucose bolus, and recheck at 30 minutes."[1]
- "If I cannot site a line within 15 minutes I give glucagon 200 microgram/kg intramuscularly. I increase the rate before the concentration, and anything above 12% goes centrally."[1]
Probe 3 — "How do you counsel the mother who wants to keep breastfeeding?"
This is a scored domain. Demonstrate it out loud: [1]
- "I reassure her the gel and the feeding plan are exactly how we protect breastfeeding — the evidence shows gel increases exclusive breastfeeding at discharge. I would encourage expressed colostrum and skin-to-skin, keep her and the baby together, and avoid formula unless it is clinically necessary."[1][3]
Probe 4 — "What is the prognosis if you treat promptly?"
- "The CHYLD cohort showed that hypoglycaemia treated to maintain at least 2.6 mmol/L was not associated with neurosensory impairment at 2 years — risk ratio 0.95. The reassurance holds for recurrent and severe episodes once the threshold is maintained."[4]
- "HypoEXIT tested a lower threshold of 2.0 mmol/L and found it non-inferior — but only in well, asymptomatic term babies, so it does not change what I do for this symptomatic preterm baby."[5]
Probe 5 — "When would you investigate for persistent disease?"
- "If the glucose infusion rate exceeds 8 mg/kg/minute in the first 24 hours, or the hypoglycaemia is recurrent, prolonged or refractory. I draw insulin, cortisol, ketones, lactate and an acyl-carnitine profile during an episode, before treatment. A glucose that needs more than 8 mg/kg/minute is the signature of hyperinsulinism."[1]
References6ShowHide
- [1]Adamkin DH Postnatal glucose homeostasis in late-preterm and term infants Pediatrics, 2011.PMID 21357346
- [2]Harris DL, Weston PJ, Signal M, et al. Dextrose gel for neonatal hypoglycaemia (the Sugar Babies Study): a randomised, double-blind, placebo-controlled trial Lancet, 2013.PMID 24075361
- [3]Edwards T, Liu G, Battin M, et al. Oral dextrose gel for the treatment of hypoglycaemia in newborn infants Cochrane Database Syst Rev, 2022.PMID 35302645
- [4]McKinlay CJ, Alsweiler JM, Ansell JM, et al. Neonatal Glycemia and Neurodevelopmental Outcomes at 2 Years N Engl J Med, 2015.PMID 26465984
- [5]van Kempen AAMW, Eskes PF, Nuytemans DHGM, et al. Lower versus Traditional Treatment Threshold for Neonatal Hypoglycemia N Engl J Med, 2020.PMID 32023373
- [6]Harding JE, Hegarty JE, Crowther CA, et al. Evaluation of oral dextrose gel for prevention of neonatal hypoglycemia (hPOD): A multicenter, double-blind randomized controlled trial PLoS Med, 2021.PMID 33507929